Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NICE (UK National Institute for Clinical Excellence) OKs insulin pump therapy

This article was originally published in Clinica

Executive Summary

The UK's National Institute for Clinical Excellence (NICE) has today (February 26 2003) recommended that the NHS offer continuous subcutaneous insulin infusion (insulin pump therapy) to treat type 1 diabetes - subject to two provisos. These are that multiple-dose insulin therapy (including insulin glargine) has failed; and that the patient has the commitment and competence to use the therapy effectively.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061263

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel